Advertisement

Late Recognition of Malignant Vasovagal Syncope

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cardiac Electrophysiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Josephson C.
        • Rahey S.
        • Sadler R.
        Neurocardiogenic syncope: frequency and consequences of its misdiagnosis as epilepsy.
        Can J Neurol Sci. 2007; 34: 221-224
        • Fitzpatrick A.
        • Theodorakis G.
        • Vardas P.
        • et al.
        The incidence of malignant vasovagal syndrome in patients with recurrent syncope.
        Eur Heart J. 1991; 12: 389-394
        • Strickberger S.
        • Benson D.
        • Biaggioni I.
        • et al.
        AHA/ACCF scientific statement on the evaluation of syncope.
        J Am Coll Cardiol. 2006; 47: 473-484
        • Sutton R.
        • Bloomfield D.
        Indications, methodology, and classification of results of tilt table testing.
        Am J Cardiol. 1999; 84: 10-19
        • Peterson M.
        • Chamberlain-Webber R.
        • Fitzpatrick A.
        • et al.
        Permanent pacing for cardioinhibitory malignant vasovagal syndrome.
        Br Heart J. 1994; 71: 274-281
        • Benditt D.
        • Sutton R.
        • Gammage M.
        • et al.
        Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group.
        Pacing Clin Electrophysiol. 1997; 20: 832-839
        • Sheldon R.
        • Koshman M.
        • Wilson W.
        • et al.
        Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally medicated syncope.
        Am J Cardiol. 1998; 81: 158-162
        • Ammirati F.
        • Collvicchi F.
        • Santini M.
        Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial.
        Circulation. 2001; 104: 52-57
        • Connolly S.
        • Sheldon R.
        • Roberts R.
        • et al.
        The North American Vasovagal Pacemaker Study (VPS). A randomised trial of permanent cardiac pacing or the prevention of vasovagal syncope.
        J Am Coll Cardiol. 1999; 33: 16-20
        • Sutton R.
        • Brignole M.
        • Menozzi C.
        • et al.
        Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope; pacemaker versus no therapy – a multicoated randomised study. The Vasovagal Syncope International Study (VASIS) Investigators.
        Circulation. 2000; 102: 294-299
        • Connolly S.
        • Sheldon R.
        • Thorpe K.
        • et al.
        Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.
        JAMA. 2003; 289: 2224-2229
        • Raviele A.
        • Giada F.
        • Menozzi C.
        • et al.
        A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The Vasovagal Syncope and Pacing Trial (SYNPACE).
        Eur Heart J. 2004; 25: 1741-1748
        • Sud S.
        • Massel D.
        • Klein G.
        • et al.
        The expectation effect and cardiac pacing for refractory vasovagal syncope.
        Am J Med. 2007; 120: 54-62
        • Brignole M.
        • Sutton R.
        • Menozzi C.
        • et al.
        Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group.
        Eur Heart J. 2006; 27: 2232-2239
        • Brignole M.
        • Sutton R.
        • Menozzi C.
        • et al.
        Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) group.
        Eur Heart J. 2006; 27: 1085-1092
        • Brignole M.
        International Study on Syncope of Uncertain Etiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design.
        Europace. 2007; 9: 25-30